Jade Biosciences Inc (JBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 14,965 | 26,165 | 24,618 | 22,066 | 21,368 |
| Operating Income | -14,965 | -26,165 | -24,618 | -22,066 | -21,368 |
| Other Income | -1,312 | 1,390 | 1,432 | 1,709 | 1,805 |
| Pre-tax Income | -16,277 | -24,775 | -23,186 | -20,357 | -19,563 |
| Net Income Continuous | -16,277 | -24,775 | -23,186 | -20,413 | -19,563 |
| Net Income | $-16,277 | $-24,775 | $-23,186 | $-20,413 | $-19,563 |
| EPS Basic Total Ops | -5.16 | -30.18 | -29.12 | -25.61 | -24.91 |
| EPS Basic Continuous Ops | -5.16 | -30.23 | -29.27 | -25.88 | -24.83 |
| EPS Diluted Total Ops | -5.16 | -30.18 | -29.12 | -25.61 | -24.91 |
| EPS Diluted Continuous Ops | -5.16 | -30.23 | -29.27 | -25.88 | -24.83 |
| EPS Diluted Before Non-Recurring Items | -19.65 | -30.18 | -29.12 | N/A | N/A |
| EBITDA(a) | $-14,965 | $-26,829 | $-25,349 | $-22,977 | $-22,151 |